bioscrip inc focus provid home
altern site infus therapi via platform
reason report
estim chang analysi sales/earn
account review
ebitda guidanc initi outlook
consensu expect gener in-lin
believ level conservat built guidanc
easier file issu thu far identifi
appear materi impact cash balanc sheet
lever least secur next coupl year
june refinanc industri tailwind evid bio
show clear oper improv largest pure-play
take revenu million
take revenu million
million y/i ebitda million
effort complet contract success exit
provid first clean look oper result
revamp manag team result disappoint
revenu revenu decreas y/i million
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
account review compani prepar financi statement identifi intern control
cure act relief
discount back
thousand except per share
total revenu
sell gener administr expens
depreci amort
incom continu oper
pre-tax incom loss continu oper
net incom loss continu oper
accru dividend prefer stock
deem dividend prefer stock
net incom loss common
sell gener administr expens
compani report stephen inc
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
